Log In
BCIQ
Print this Print this
 

sPLA2 activity test

  Manage Alerts
Collapse Summary General Information
Company Aterovax S.A.
DescriptionTest for secretory phospholipase A2 (sPLA2) activity in blood plasma
Molecular Target Secretory phospholipase A2 (PLA2G2A ) (sPLA2)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDetermine risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS); Predict risk of cardiovascular death, myocardial infarction (MI) or stroke
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/30/2010

Undisclosed

Undisclosed

Undisclosed

04/26/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today